Lesueur F Mebirouk N Engel C Schmutzler RK Barrowdale D Davies E Eccles DM Evans DG Chenevix-Trench G Adank MA Devilee P van der Hout AH Dareng EO Tyrer JP Jones MR Aben KKH Anton-Culver H Antonenkova NN Aravantinos G Beckmann MW Beeghly-Fadiel A Benitez J Bermisheva M Bernardini MQ Bjorge L Bogdanova NV Brenton JD Budzilowska A Butzow R Cai H Campbell I Cannioto R Chang-Claude J Chanock SJ Chen K Chiew YE Cook LS Dao F Dennis J Doherty JA Dörk T du Bois A Dürst M Eccles DM Eliassen HA Fasching PA Flanagan JM Fortner RT Giles GG Goodman MT Gronwald J Haiman CA Håkansson N Harris HR Heitz F Hildebrandt MAT Høgdall E Høgdall CK Huang RY Huff C Huntsman DG Jakubowska A Jensen A Jones ME Kang D Karlan BY Karnezis A Kelemen LE Khusnutdinova E Kiemeney LA Kim BG Kjaer SK Kupryjanczyk J Lambrechts D Larson MC Le ND Lester J Levine DA Lu KH Lubiński J Marks JR Matsuno RK Matsuo K May T McLaughlin JR McNeish IA Milne RL Minlikeeva A Modugno F Moysich KB Munro E Nevanlinna H Odunsi K Olbrecht S Olson SH Olsson H Osorio A Park SK Pejovic T Permuth JB Piskorz A Prokofyeva D Riggan MJ Risch HA Rodriguez-Antona C Rossing MA Runnebaum I Sandler DP Setiawan VW Shan K Sieh W Song H Southey MC Steed H Sutphen R Swerdlow AJ Teo SH Terry KL Thompson PJ Thomsen LCV Titus L Trabert B Travis R Tworoger SS Valen E van Altena AM Van Nieuwenhuysen E Edwards DV Vierkant RA Wang F Webb PM Weinberg CR Wentzensen N White E Whittemore AS Winham SJ Wolk A Woo YL Wu AH Yan L Yannoukakos D Zheng W Ziogas A Lawrenson K deFazio A Ramus SJ Pearce CL Monteiro AN Cunningham JM Goode EL Schildkraut JM Berchuck A Gayther SA Pharoah PDP Barnes DR Yang X Adank MA Agata S Andrulis IL Arun BK Augustinsson A Balmaña J Barkardottir RB Barrowdale D Bonanni B Borg A Buys SS Caligo MA Cassingham H Chung WK Claes KBM Colonna S Couch FJ Daly MB Davies E de la Hoya M de Putter R DePersia A Devilee P Diez O Ding YC Domchek SM Eccles DM Engel C Evans DG Machackova E Friedman E Ganz PA Garber J Gensini F Glendon G Godwin AK Greene MH Hahnen E Hamann U Hansen TVO Hartman M Hopper JL Hulick PJ Imyanitov EN Isaacs C James PA Janavicius R Johannsson OT John EM Komenaka I Kurian AW Kwong A Lazaro C Leslie G Lesueur F Li J Loud JT Mai PL Manoukian S McGuffog L Mebirouk N Miller A Montagna M Nathanson KL Neuhausen SL Yie JNY Nielsen HR Nikitina-Zake L Offit K Olah E Olopade OI Papi L Parsons MT Pathak H Pedersen IS Peixoto A Perez-Segura P Peshkin B Peterlongo P Radice P Rantala J Ross E Santamariña M Soucy P Schmutzler RK Simard J Singer CF Sokolenko AP Stoppa-Lyonnet D Tan YY Teixeira MR Terry MB Thomassen M Thull DL Tischkowitz M Toland AE Torres D Tung N van der Hout AH van Rensburg EJ Vega A Wappenschmidt B Weitzel JN Zavaglia KM Zorn KK Sellers TA Chenevix-Trench G Antoniou AC

¹University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK.
²University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, UK.
³University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK.
⁴Center for Bioinformatics and Functional Genomics, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
⁵University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK.
⁶Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.
⁷The Netherlands Cancer Institute-Antoni van Leeuwenhoek hospital, Family Cancer Clinic, Amsterdam, The Netherlands.
⁸Veneto Institute of Oncology IOV-IRCCS, Immunology and Molecular Oncology Unit, Padua, Italy.
⁹Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Fred A. Litwin Center for Cancer Genetics, Toronto, ON, Canada.
¹⁰University of California Irvine, Department of Epidemiology, Genetic Epidemiology Research Institute, Irvine, CA, USA.
¹¹N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus.
¹²'Agii Anargiri' Cancer Hospital, Athens, Greece.
¹³University of Texas MD Anderson Cancer Center, Department of Breast Medical Oncology, Houston, TX, USA.
¹⁴Lund University, Department of Cancer Epidemiology, Clinical Sciences, Lund, Sweden.
¹⁵Vall d'Hebron Institute of Oncology, Hereditary cancer Genetics Group, Barcelona, Spain.
¹⁶Rutgers Cancer Institute of New Jersey, Cancer Prevention and Control Program, New Brunswick, NJ, USA.
¹⁷Landspitali University Hospital, Department of Pathology, Reykjavik, Iceland.
¹⁸University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK.
¹⁹University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, Erlangen, Germany.
²⁰Vanderbilt University School of Medicine, Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
²¹Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain.
²²Ufa Federal Research Centre of the Russian Academy of Sciences, Institute of Biochemistry and Genetics, Ufa, Russia.
²³Princess Margaret Hospital, Division of Gynecologic Oncology, University Health Network, Toronto, ON, Canada.
²⁴Haukeland University Hospital, Department of Obstetrics and Gynecology, Bergen, Norway.
²⁵National Cancer Institute, Division of Cancer Epidemiology and Genetics, Bethesda, MD, USA.
²⁶N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus.
²⁷IEO, European Institute of Oncology IRCCS, Division of Cancer Prevention and Genetics, Milan, Italy.
²⁸Lund University and Skåne University Hospital, Department of Oncology, Lund, Sweden.
²⁹Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
³⁰Maria Sklodowska-Curie National Research Institute of Oncology, Department of Pathology and Laboratory Diagnostics, Warsaw, Poland.
³¹University of Helsinki, Department of Pathology, Helsinki University Hospital, Helsinki, Finland.
³²Huntsman Cancer Institute, Department of Medicine, Salt Lake City, UT, USA.
³³Vanderbilt University School of Medicine, Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
³⁴University Hospital, SOD Genetica Molecolare, Pisa, Italy.
³⁵Peter MacCallum Cancer Center, Melbourne, VIC, Australia.
³⁶Roswell Park Cancer Institute, Cancer Pathology & Prevention, Division of Cancer Prevention and Population Sciences, Buffalo, NY, USA.
³⁷Division of Human Genetics, The Ohio State University, Department of Internal Medicine, Columbus, OH, USA.
³⁸German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany.
³⁹National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, Bethesda, MD, USA.
⁴⁰Tianjin Medical University Cancer Institute and Hospital, Department of Epidemiology, Tianjin, China.
⁴¹The University of Sydney, Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, NSW, Australia.
⁴²Columbia University, Departments of Pediatrics and Medicine, New York, NY, USA.
⁴³Ghent University, Centre for Medical Genetics, Gent, Belgium.
⁴⁴Huntsman Cancer Institute, Department of Medicine, Salt Lake City, UT, USA.
⁴⁵University of New Mexico, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
⁴⁶Mayo Clinic, Department of Laboratory Medicine and Pathology, Rochester, MN, USA.
⁴⁷Fox Chase Cancer Center, Department of Clinical Genetics, Philadelphia, PA, USA.
⁴⁸Memorial Sloan Kettering Cancer Center, Gynecology Service, Department of Surgery, New York, NY, USA.
⁴⁹Cambridge, Cambridge, UK.
⁵⁰CIBERONC, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Molecular Oncology Laboratory, Madrid, Spain.
⁵¹Ghent University, Centre for Medical Genetics, Gent, Belgium.
⁵²University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK.
⁵³NorthShore University Health System, Center for Medical Genetics, Evanston, IL, USA.
⁵⁴Leiden University Medical Center, Department of Pathology, Leiden, The Netherlands.
⁵⁵Vall dHebron Institute of Oncology (VHIO), Oncogenetics Group, Barcelona, Spain.
⁵⁶Beckman Research Institute of City of Hope, Department of Population Sciences, Duarte, CA, USA.
⁵⁷University of Utah, Huntsman Cancer Institute, Department of Population Health Sciences, Salt Lake City, UT, USA.
⁵⁸University of Pennsylvania, Basser Center for BRCA, Abramson Cancer Center, Philadelphia, PA, USA.
⁵⁹Hannover Medical School, Gynaecology Research Unit, Hannover, Germany.
⁶⁰Ev. Kliniken Essen-Mitte (KEM), Department of Gynecology and Gynecologic Oncology, Essen, Germany.
⁶¹Jena University Hospital-Friedrich Schiller University, Department of Gynaecology, Jena, Germany.
⁶²University of Southampton, Faculty of Medicine, Southampton, UK.
⁶³Harvard T.H. Chan School of Public Health, Department of Epidemiology, Boston, MA, USA.
⁶⁴University of Leipzig, Institute for Medical Informatics, Statistics and Epidemiology, Leipzig, Germany.
⁶⁵University of Manchester, Manchester Academic Health Science Centre, Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester, UK.
⁶⁶University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, Erlangen, Germany.
⁶⁷Imperial College London, Division of Cancer and Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, London, UK.
⁶⁸German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany.
⁶⁹Masaryk Memorial Cancer Institute, Department of Cancer Epidemiology and Genetics, Brno, Czech Republic.
⁷⁰Chaim Sheba Medical Center, The Susanne Levy Gertner Oncogenetics Unit, Ramat Gan, Israel.
⁷¹Jonsson Comprehensive Cancer Centre, UCLA, Schools of Medicine and Public Health, Division of Cancer Prevention & Control Research, Los Angeles, CA, USA.
⁷²Dana-Farber Cancer Institute, Cancer Risk and Prevention Clinic, Boston, MA, USA.
⁷³University of Florence, Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', Medical Genetics Unit, Florence, Italy.
⁷⁴Cancer Council Victoria, Cancer Epidemiology Division, Melbourne, VIC, Australia.
⁷⁵Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Fred A. Litwin Center for Cancer Genetics, Toronto, ON, Canada.
⁷⁶University of Kansas Medical Center, Department of Pathology and Laboratory Medicine, Kansas City, KS, USA.
⁷⁷Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Cancer Prevention and Genetics Program, Los Angeles, CA, USA.
⁷⁸National Cancer Institute, Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, Bethesda, MD, USA.
⁷⁹Pomeranian Medical University, Department of Genetics and Pathology, Szczecin, Poland.
⁸⁰Faculty of Medicine and University Hospital Cologne, University of Cologne, Center for Familial Breast and Ovarian Cancer, Cologne, Germany.
⁸¹University of Southern California, Department of Preventive Medicine, Keck School of Medicine, Los Angeles, CA, USA.
⁸²Karolinska Institutet, Institute of Environmental Medicine, Stockholm, Sweden.
⁸³German Cancer Research Center (DKFZ), Molecular Genetics of Breast Cancer, Heidelberg, Germany.
⁸⁴Rigshospitalet, Copenhagen University Hospital, Department of Clinical Genetics, Copenhagen, Denmark.
⁸⁵Fred Hutchinson Cancer Research Center, Program in Epidemiology, Division of Public Health Sciences, Seattle, WA, USA.
⁸⁶National University of Singapore and National University Health System, Saw Swee Hock School of Public Health, Singapore, Singapore.
⁸⁷Ev. Kliniken Essen-Mitte (KEM), Department of Gynecology and Gynecologic Oncology, Essen, Germany.
⁸⁸University of Texas MD Anderson Cancer Center, Department of Epidemiology, Houston, TX, USA.
⁸⁹Danish Cancer Society Research Center, Department of Virus, Lifestyle and Genes, Copenhagen, Denmark.
⁹⁰University of Copenhagen, Department of Gynaecology, Rigshospitalet, Copenhagen, Denmark.
⁹¹The University of Melbourne, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, Melbourne, VIC, Australia.
⁹²Roswell Park Cancer Institute, Center For Immunotherapy, Buffalo, NY, USA.
⁹³University of Texas MD Anderson Cancer Center, Department of Epidemiology, Houston, TX, USA.
⁹⁴NorthShore University Health System, Center for Medical Genetics, Evanston, IL, USA.
⁹⁵BC Cancer, Vancouver General Hospital, and University of British Columbia, British Columbia's Ovarian Cancer Research (OVCARE) Program, Vancouver, BC, Canada.
⁹⁶N.N. Petrov Institute of Oncology, St. Petersburg, Russia.
⁹⁷Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
⁹⁸Pomeranian Medical University, Department of Genetics and Pathology, Szczecin, Poland.
⁹⁹The University of Melbourne, Sir Peter MacCallum Department of Oncology, Melbourne, VIC, Australia.
¹⁰⁰Vilnius University Hospital Santariskiu Clinics, Hematology, oncology and transfusion medicine center, Dept. of Molecular and Regenerative Medicine, Vilnius, Lithuania.
¹⁰¹Danish Cancer Society Research Center, Department of Virus, Lifestyle and Genes, Copenhagen, Denmark.
¹⁰²Landspitali University Hospital, Department of Oncology, Reykjavik, Iceland.
¹⁰³Stanford University School of Medicine, Department of Epidemiology & Population Health, Stanford, CA, USA.
¹⁰⁴The Institute of Cancer Research, Division of Genetics and Epidemiology, London, UK.
¹⁰⁵Seoul National University College of Medicine, Department of Preventive Medicine, Seoul, Korea.
¹⁰⁶University of California at Los Angeles, David Geffen School of Medicine, Department of Obstetrics and Gynecology, Los Angeles, CA, USA.
¹⁰⁷UC Davis Medical Center, Department of Pathology and Laboratory Medicine, Sacramento, CA, USA.
¹⁰⁸Medical University of South Carolina, Hollings Cancer Center, Charleston, SC, USA.
¹⁰⁹Ufa Federal Research Centre of the Russian Academy of Sciences, Institute of Biochemistry and Genetics, Ufa, Russia.
¹¹⁰Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.
¹¹¹Sungkyunkwan University School of Medicine, Department of Obstetrics and Gynecology, Samsung Medical Center, Seoul, Korea.
¹¹²Danish Cancer Society Research Center, Department of Virus, Lifestyle and Genes, Copenhagen, Denmark.
¹¹³City of Hope Clinical Cancer Genetics Community Research Network, Duarte, CA, USA.
¹¹⁴Maria Sklodowska-Curie National Research Institute of Oncology, Department of Pathology and Laboratory Diagnostics, Warsaw, Poland.
¹¹⁵Stanford University School of Medicine, Department of Epidemiology & Population Health, Stanford, CA, USA.
¹¹⁶Cancer Genetics Centre, Hong Kong Hereditary Breast Cancer Family Registry, Happy Valley, Hong Kong.
¹¹⁷VIB Center for Cancer Biology, Leuven, Belgium.
¹¹⁸Mayo Clinic, Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Rochester, MN, USA.
¹¹⁹ONCOBELL-IDIBELL-IGTP, Catalan Institute of Oncology, CIBERONC, Hereditary Cancer Program, Barcelona, Spain.
¹²⁰BC Cancer, Cancer Control Research, Vancouver, BC, Canada.
¹²¹University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK.
¹²²University of California at Los Angeles, David Geffen School of Medicine, Department of Obstetrics and Gynecology, Los Angeles, CA, USA.
¹²³Institut Curie, Paris, France.
¹²⁴Memorial Sloan Kettering Cancer Center, Gynecology Service, Department of Surgery, New York, NY, USA.
¹²⁵Tianjin Medical University Cancer Institute and Hospital, Department of Epidemiology, Tianjin, China.
¹²⁶Genome Institute of Singapore, Human Genetics Division, Singapore, Singapore.
¹²⁷National Cancer Institute, Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, Bethesda, MD, USA.
¹²⁸University of Texas MD Anderson Cancer Center, Department of Gynecologic Oncology and Clinical Cancer Genetics Program, Houston, TX, USA.
¹²⁹Pomeranian Medical University, Department of Genetics and Pathology, Szczecin, Poland.
¹³⁰Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
¹³¹Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Unit of Medical Genetics, Department of Medical Oncology and Hematology, Milan, Italy.
¹³²Duke University Hospital, Department of Surgery, Durham, NC, USA.
¹³³University of Hawaii Cancer Center, Cancer Epidemiology Program, Honolulu, HI, USA.
¹³⁴Aichi Cancer Center Research Institute, Division of Cancer Epidemiology and Prevention, Nagoya, Japan.
¹³⁵Princess Margaret Hospital, Division of Gynecologic Oncology, University Health Network, Toronto, ON, Canada.
¹³⁶University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK.
¹³⁷Samuel Lunenfeld Research Institute, Public Health Ontario, Toronto, ON, Canada.
¹³⁸Imperial College London, Division of Cancer and Ovarian Cancer Action Research Centre, Department Surgery & Cancer, London, UK.
¹³⁹Institut Curie, Paris, France.
¹⁴⁰University College London, MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London, UK.
¹⁴¹Roswell Park Cancer Institute, NRG Oncology, Statistics and Data Management Center, Buffalo, NY, USA.
¹⁴²Cancer Council Victoria, Cancer Epidemiology Division, Melbourne, VIC, Australia.
¹⁴³Roswell Park Cancer Institute, Division of Cancer Prevention and Control, Buffalo, NY, USA.
¹⁴⁴Magee-Womens Research Institute and Hillman Cancer Center, Womens Cancer Research Center, Pittsburgh, PA, USA.
¹⁴⁵Veneto Institute of Oncology IOV-IRCCS, Immunology and Molecular Oncology Unit, Padua, Italy.
¹⁴⁶Roswell Park Cancer Institute, Division of Cancer Prevention and Control, Buffalo, NY, USA.
¹⁴⁷Oregon Health & Science University, Department of Obstetrics and Gynecology, Portland, OR, USA.
¹⁴⁸University of Pennsylvania, Basser Center for BRCA, Abramson Cancer Center, Philadelphia, PA, USA.
¹⁴⁹Beckman Research Institute of City of Hope, Department of Population Sciences, Duarte, CA, USA.
¹⁵⁰University of Helsinki, Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland.
¹⁵¹National Cancer Centre, Cancer Genetics Service, Singapore, Singapore.
¹⁵²Odense University Hospital, Department of Clinical Genetics, Odence C, Denmark.
¹⁵³Rigshospitalet, Copenhagen University Hospital, Department of Clinical Genetics, Copenhagen, Denmark.
¹⁵⁴Latvian Biomedical Research and Study Centre, Riga, Latvia.
¹⁵⁵Roswell Park Cancer Institute, Department of Gynecologic Oncology, Buffalo, NY, USA.
¹⁵⁶Memorial Sloan Kettering Cancer Center, Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, New York, NY, USA.
¹⁵⁷National Institute of Oncology, Department of Molecular Genetics, Budapest, Hungary.
¹⁵⁸University Hospitals Leuven, Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology and Leuven Cancer Institute, Leuven, Belgium.
¹⁵⁹The University of Chicago, Center for Clinical Cancer Genetics, Chicago, IL, USA.
¹⁶⁰Memorial Sloan-Kettering Cancer Center, Department of Epidemiology and Biostatistics, New York, NY, USA.
¹⁶¹Lund University, Department of Cancer Epidemiology, Clinical Sciences, Lund, Sweden.
¹⁶²Spanish National Cancer Research Centre (CNIO), Human Cancer Genetics Programme, Madrid, Spain.
¹⁶³University of Florence, Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', Medical Genetics Unit, Florence, Italy.
¹⁶⁴Seoul National University College of Medicine, Department of Preventive Medicine, Seoul, Korea.
¹⁶⁵QIMR Berghofer Medical Research Institute, Department of Genetics and Computational Biology, Brisbane, QLD, Australia.
¹⁶⁶University of Kansas Medical Center, Department of Pathology and Laboratory Medicine, Kansas City, KS, USA.
¹⁶⁷Aalborg University Hospital, Molecular Diagnostics, Aalborg, Denmark.
¹⁶⁸Portuguese Oncology Institute, Department of Genetics, Porto, Portugal.
¹⁶⁹Oregon Health & Science University, Department of Obstetrics and Gynecology, Portland, OR, USA.
¹⁷⁰CIBERONC, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Molecular Oncology Laboratory, Madrid, Spain.
¹⁷¹Moffitt Cancer Center, Department of Cancer Epidemiology, Tampa, FL, USA.
¹⁷²Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
¹⁷³IFOM-the FIRC Institute of Molecular Oncology, Genome Diagnostics Program, Milan, Italy.
¹⁷⁴Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
¹⁷⁵Bashkir State University, Department of Genetics and Fundamental Medicine, Ufa, Russia.
¹⁷⁶Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Milan, Italy.
¹⁷⁷Karolinska Institutet, Clinical Genetics, Stockholm, Sweden.
¹⁷⁸Duke University Hospital, Department of Gynecologic Oncology, Durham, NC, USA.
¹⁷⁹Yale School of Public Health, Chronic Disease Epidemiology, New Haven, CT, USA.
¹⁸⁰Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain.
¹⁸¹Fox Chase Cancer Center, Population Studies Facility, Philadelphia, PA, USA.
¹⁸²Fred Hutchinson Cancer Research Center, Program in Epidemiology, Division of Public Health Sciences, Seattle, WA, USA.
¹⁸³Jena University Hospital-Friedrich Schiller University, Department of Gynaecology, Jena, Germany.
¹⁸⁴National Institute of Environmental Health Sciences, NIH, Epidemiology Branch, Research Triangle Park, NC, USA.
¹⁸⁵Centro de Investigación en Red de Enfermedades Raras (CIBERER), Madrid, Spain.
¹⁸⁶Centre Hospitalier Universitaire de Québec - Université Laval Research Center, Genomics Center, Québec City, QC, Canada.
¹⁸⁷Faculty of Medicine and University Hospital Cologne, University of Cologne, Center for Familial Breast and Ovarian Cancer, Cologne, Germany.
¹⁸⁸University of Southern California, Department of Preventive Medicine, Keck School of Medicine, Los Angeles, CA, USA.
¹⁸⁹Hebei Medical University, Fourth Hospital, Department of Obstetrics and Gynaecology, Shijiazhuang, China.
¹⁹⁰Icahn School of Medicine at Mount Sinai, Department of Population Health Science and Policy, New York, NY, USA.
¹⁹¹Centre Hospitalier Universitaire de Québec-Université Laval Research Center, Genomic Center, Québec City, QC, Canada.
¹⁹²Medical University of Vienna, Dept of OB/GYN and Comprehensive Cancer Center, Vienna, Austria.
¹⁹³N.N. Petrov Institute of Oncology, St. Petersburg, Russia.
¹⁹⁴University of Cambridge, Department of Public Health and Primary Care, Cambridge, UK.
¹⁹⁵Cancer Council Victoria, Cancer Epidemiology Division, Melbourne, VIC, Australia.
¹⁹⁶Royal Alexandra Hospital, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Edmonton, AB, Canada.
¹⁹⁷INSERM U830, Department of Tumour Biology, Paris, France.
¹⁹⁸University of South Florida, Epidemiology Center, College of Medicine, Tampa, FL, USA.
¹⁹⁹The Institute of Cancer Research, Division of Genetics and Epidemiology, London, UK.
²⁰⁰Medical University of Vienna, Dept of OB/GYN and Comprehensive Cancer Center, Vienna, Austria.
²⁰¹Portuguese Oncology Institute, Department of Genetics, Porto, Portugal.
²⁰²Cancer Research Malaysia, Breast Cancer Research Programme, Subang Jaya, Selangor, Malaysia.
²⁰³Harvard T.H. Chan School of Public Health, Department of Epidemiology, Boston, MA, USA.
²⁰⁴Columbia University, Department of Epidemiology, Mailman School of Public Health, New York, NY, USA.
²⁰⁵Odense University Hospital, Department of Clinical Genetics, Odence C, Denmark.
²⁰⁶Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Cancer Prevention and Genetics Program, Los Angeles, CA, USA.
²⁰⁷Haukeland University Hospital, Department of Obstetrics and Gynecology, Bergen, Norway.
²⁰⁸Magee-Womens Hospital, University of Pittsburgh School of Medicine, Department of Medicine, Pittsburgh, PA, USA.
²⁰⁹McGill University, Program in Cancer Genetics, Departments of Human Genetics and Oncology, Montréal, QC, Canada.
²¹⁰Dartmouth College, Geisel School of Medicine, Hanover, NH, USA.
²¹¹The Ohio State University, Department of Cancer Biology and Genetics, Columbus, OH, USA.
²¹²German Cancer Research Center (DKFZ), Molecular Genetics of Breast Cancer, Heidelberg, Germany.
²¹³National Cancer Institute, Division of Cancer Epidemiology and Genetics, Bethesda, MD, USA.
²¹⁴University of Oxford, Cancer Epidemiology Unit, Oxford, UK.
²¹⁵Beth Israel Deaconess Medical Center, Department of Medical Oncology, Boston, MA, USA.
²¹⁶Harvard T.H. Chan School of Public Health, Department of Epidemiology, Boston, MA, USA.
²¹⁷Haukeland University Hospital, Department of Obstetrics and Gynecology, Bergen, Norway.
²¹⁸Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.
²¹⁹University Medical Center Groningen, University Groningen, Department of Genetics, Groningen, The Netherlands.
²²⁰University Hospitals Leuven, Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology and Leuven Cancer Institute, Leuven, Belgium.
²²¹University of Pretoria, Department of Genetics, Arcadia, South Africa.
²²²Centro de Investigación en Red de Enfermedades Raras (CIBERER), Madrid, Spain.
²²³Vanderbilt University Medical Center, Division of Quantitative Sciences, Department of Obstetrics and Gynecology, Department of Biomedical Sciences, Women's Health Research, Nashville, TN, USA.
²²⁴Mayo Clinic, Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Rochester, MN, USA.
²²⁵Duke Cancer Institute, Cancer Control and Population Sciences, Durham, NC, USA.
²²⁶Faculty of Medicine and University Hospital Cologne, University of Cologne, Center for Familial Breast and Ovarian Cancer, Cologne, Germany.
²²⁷QIMR Berghofer Medical Research Institute, Population Health Department, Brisbane, QLD, Australia.
²²⁸National Institute of Environmental Health Sciences, NIH, Biostatistics and Computational Biology Branch, Research Triangle Park, NC, USA.
²²⁹City of Hope, Clinical Cancer Genomics, Duarte, CA, USA.
²³⁰National Cancer Institute, Division of Cancer Epidemiology and Genetics, Bethesda, MD, USA.
²³¹University of Washington, Department of Epidemiology, Seattle, WA, USA.
²³²Stanford University School of Medicine, Department of Epidemiology & Population Health, Stanford, CA, USA.
²³³Mayo Clinic, Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Rochester, MN, USA.
²³⁴Karolinska Institutet, Institute of Environmental Medicine, Stockholm, Sweden.
²³⁵University of Malaya, Department of Obstetrics and Gynaecology, University of Malaya Medical Centre, Kuala Lumpur, Malaysia.
²³⁶University of Southern California, Department of Preventive Medicine, Keck School of Medicine, Los Angeles, CA, USA.
²³⁷Hebei Medical University, Fourth Hospital, Department of Molecular Biology, Shijiazhuang, China.
²³⁸National Centre for Scientific Research 'Demokritos', Molecular Diagnostics Laboratory, INRASTES, Athens, Greece.
²³⁹University Hospital, SOD Genetica Molecolare, Pisa, Italy.
²⁴⁰Vanderbilt University School of Medicine, Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
²⁴¹University of California Irvine, Department of Epidemiology, Genetic Epidemiology Research Institute, Irvine, CA, USA.
²⁴²Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
²⁴³Institute of Biochemistry and Experimental Oncology, First Faculty od Medicine, Charles University, Prague, Czech Republic.
²⁴⁴University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK.
²⁴⁵Center for Bioinformatics and Functional Genomics, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
²⁴⁶The University of Sydney, Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, NSW, Australia.
²⁴⁷Royal Pass Road, Tampa, FL, USA.
²⁴⁸University of NSW Sydney, School of Women's and Children's Health, Faculty of Medicine, Sydney, NSW, Australia.
²⁴⁹University of Michigan School of Public Health, Department of Epidemiology, Ann Arbor, MI, USA.
²⁵⁰Moffitt Cancer Center, Department of Cancer Epidemiology, Tampa, FL, USA.
²⁵¹Mayo Clinic, Department of Health Science Research, Division of Epidemiology, Rochester, MN, USA.
²⁵²Mayo Clinic, Department of Health Science Research, Division of Epidemiology, Rochester, MN, USA.
²⁵³Emory University, Department of Epidemiology, Rollins School of Public Health, Atlanta, GA, USA.
²⁵⁴Duke University Hospital, Department of Gynecologic Oncology, Durham, NC, USA.
²⁵⁵QIMR Berghofer Medical Research Institute, Department of Genetics and Computational Biology, Brisbane, QLD, Australia.
²⁵⁶Center for Bioinformatics and Functional Genomics, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
²⁵⁷University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK.
²⁵⁸University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK. pp10001@medschl.cam.ac.uk.